GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $11,745,000 | +20.6% | 101,773 | +1.8% | 0.00% | 0.0% |
| Q3 2020 | $9,735,000 | -20.7% | 100,003 | 0.0% | 0.00% | -25.0% |
| Q2 2020 | $12,272,000 | +40.1% | 100,003 | +0.0% | 0.00% | 0.0% |
| Q1 2020 | $8,757,000 | -84.7% | 100,000 | -81.8% | 0.00% | -77.8% |
| Q4 2019 | $57,382,000 | +1.4% | 548,794 | +11.5% | 0.02% | +20.0% |
| Q3 2019 | $56,617,000 | -35.1% | 492,194 | -2.8% | 0.02% | -31.8% |
| Q2 2019 | $87,271,000 | +29.0% | 506,244 | +26.2% | 0.02% | -4.3% |
| Q1 2019 | $67,647,000 | +97.5% | 401,299 | +14.1% | 0.02% | +76.9% |
| Q4 2018 | $34,247,000 | -43.3% | 351,651 | +0.5% | 0.01% | -31.6% |
| Q3 2018 | $60,453,000 | +7.9% | 349,967 | -12.8% | 0.02% | 0.0% |
| Q2 2018 | $56,012,000 | +40.4% | 401,399 | +13.3% | 0.02% | +26.7% |
| Q1 2018 | $39,905,000 | -16.0% | 354,177 | -1.6% | 0.02% | -11.8% |
| Q4 2017 | $47,493,000 | +12.7% | 359,766 | -13.4% | 0.02% | +6.2% |
| Q3 2017 | $42,144,000 | +79417.0% | 415,256 | +96247.1% | 0.02% | – |
| Q2 2015 | $53,000 | +47.2% | 431 | +9.9% | 0.00% | – |
| Q1 2015 | $36,000 | +56.5% | 392 | +15.0% | 0.00% | – |
| Q4 2014 | $23,000 | -8.0% | 341 | +9.6% | 0.00% | – |
| Q3 2014 | $25,000 | -16.7% | 311 | +12.3% | 0.00% | – |
| Q2 2014 | $30,000 | +130.8% | 277 | +22.0% | 0.00% | – |
| Q1 2014 | $13,000 | – | 227 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|